Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Lingling Du

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100516323. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo.2019.11.06↗
  2. Trends in Neoadjuvant Approaches in Pancreatic Cancer. Co-author DOI 10.6004/jnccn.2017.0134↗
  3. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.hoc.2015.04.011↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Wang‐Gillam · 3 shared papers, 2015–2020 · strength 0.31
  2. Patrick M. Grierson · 1 shared paper, 2020 · strength 0.10
  3. Andrea S. Teague · 1 shared paper, 2020 · strength 0.10
  4. Katrina Sophia Pedersen · 1 shared paper, 2020 · strength 0.10
  5. Kian‐Huat Lim · 1 shared paper, 2020 · strength 0.10
  6. Albert Craig Lockhart · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.